Robert M. Kliegman
Neonatal technology, perinatal survival, social consequences, and the perinatal paradox.
exogenous surfactant therapy premature infants respiratory distress syndrome significant impact infant mortality complications prematurity yet total number lowbirthweight infants declined resulting highrisk population would require surfactant therapy longterm child care surviving lowbirthweight infants despite surfactant therapy remain risk consequences premature birth neurosensory impairment cerebral palsy chronic lung disease addition close association poverty low birthweight surviving premature infants increased risk new morbidities violence homelessness child abuse neglect addictive drug use goal reduce risk born low birthweight rather treat consequences premature gestation despite marvelous advances permit us treat respiratory distress syndrome continuing high lowbirthweight rate places significant strain health care system goal redirected identifying large populationbased efforts reduce number lowbirthweight infants